BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 71205)

  • 1. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
    Anderson T; Bender RA; Fisher RI; DeVita VT; Chabner BA; Berard CW; Norton L; Young RC
    Cancer Treat Rep; 1977 Sep; 61(6):1057-66. PubMed ID: 71205
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
    Bonadonna G; Monfardini S; Villa E
    Cancer Treat Rep; 1977 Sep; 61(6):1117-23. PubMed ID: 71209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
    Bennett JM; Lenhard RE; Ezdinli E; Johnson GJ; Carbone PP; Pocock SJ
    Cancer Treat Rep; 1977 Sep; 61(6):1079-83. PubMed ID: 71207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.
    Coltman CA; Luce JK; McKelvey EM; Jones SE; Moon TE
    Cancer Treat Rep; 1977 Sep; 61(6):1067-78. PubMed ID: 71206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
    Nissen NI; Pajak T; Glidewell O; Blom H; Flaherty M; Hayes D; McIntyre R; Holland JF
    Cancer Treat Rep; 1977 Sep; 61(6):1097-107. PubMed ID: 71208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
    Bonadonna G; Zucali R; De Lena M; Valagussa P
    Cancer Treat Rep; 1977 Aug; 61(5):769-77. PubMed ID: 70270
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group.
    Bennett JM; Bakemeier RF; Carbone PP; Ezdinli E; Lenhard RE
    Cancer Treat Rep; 1976 Jun; 60(6):739-45. PubMed ID: 60176
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
    Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of non-Hodgkin malignant lymphomas].
    Gociu M; Coliţă D; Leahu S; Ciocoiu A; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):1-10. PubMed ID: 6145200
    [No Abstract]   [Full Text] [Related]  

  • 11. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Hodgkin's lymphomas-present status of chemotherapy.
    Young CW
    Clin Bull; 1975; 5(1):20-3. PubMed ID: 776444
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR; Gams RA; Bartolucci AA; Dorfman RF
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
    Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.
    Bonadonna G; De Lena M; Lattuada A; Milani F; Monfardini S; Beretta G
    Br J Cancer Suppl; 1975 Mar; 2():481-8. PubMed ID: 52367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The practice of chemotherapy with the DeVita protocol].
    Gassmann W; Schmitz N; Löffler H
    Dtsch Med Wochenschr; 1982 Jul; 107(27):1063-9. PubMed ID: 6177488
    [No Abstract]   [Full Text] [Related]  

  • 19. Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination.
    Young RC; Johnson RE; Canellos GP; Chabner BA; Brereton HD; Berard CW; DeVita VT
    Cancer Treat Rep; 1977 Sep; 61(6):1153-9. PubMed ID: 332349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience.
    Portlock CS; Rosenberg SA
    Cancer Treat Rep; 1977 Sep; 61(6):1049-55. PubMed ID: 332344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.